Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Our lead product Detach™ is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.
Latest news All news
CommSec’s Tom Piotrowski speaks with Anatara Lifesciences (ANR) Chief Scientific Officer, Dr Tracey Mynott about its non-antibiotic treatment for gastrointestinal diseases in production animals.
Click here to view the interview.
Anatara Lifesciences is pleased to release its most recent investor presentation and market update, and to announce that Dr Paul Schober has been appointed as Managing Director effective today.
Please click here to view the ASX announcement and investor presentation.